PG2

Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Stroke Phase 2 ClinicalTrials
Purpura; Purpura, Thrombocytopenic; Purpura, Thrombocytopenic, Idiopathic Phase 2 ClinicalTrials
Fatigue Phase 2/Phase 3 ClinicalTrials
Intracranial Hemorrhages; Stroke Early Phase 1 ClinicalTrials
Fatigue Phase 2/Phase 3 ClinicalTrials
Neoplasm Metastasis; Neoplasms; Recurrence Phase 1/Phase 2 ClinicalTrials
Fatigue Phase 2 ClinicalTrials
CONTENTS